• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Section Contents Menu

Transparency

Transparency Reports

Reports on the proposals released for public comment and progress made in the implementation of the FDA's Transparency Initiative

Public Disclosure Policies

On May 19, 2010, the Transparency Task Force released a report containing 21 draft proposals about expanding the disclosure of information by FDA while maintaining confidentiality for trade secrets and individually identifiable patient information.

Transparency to Regulated Industry

On January 6, 2011, FDA released a report containing 19 action items and five draft proposals to improve transparency to regulated industry.

Good Guidance Practices

In December 2011, FDA issued a report focused on improving the transparency and efficiency of the Agency's guidance development processes.

Increasing Access to Compliance and Enforcement Data

On October 3, 2011, FDA released a new report that contains eight draft proposals to improve access to FDA's compliance and enforcement data.

On January 31, 2012, FDA released a new transparency report on eight proposed initiatives to explore avenues for making FDA’s compliance and enforcement data more accessible and user-friendly.

On April 22, 2014, FDA released a report recommending ways to enhance the transparency and public accessibility of the Agency’s compliance and enforcement data. 

 

-